Virax Biolabs Debuts ImmuneSelect Portfolio
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC
EXCLUSIVE: Virax Biolabs Tells Benzinga 'The Launch Marks a Significant Milestone for Virax as It Brings Us a Step Closer to Commercializing ViraxImmuneTM as a Full In-Vitro-Diagnostic Product'
EXCLUSIVE: Virax Biolabs Tells Benzinga 'The Launch Marks a Significant Milestone for Virax as It Brings Us a Step Closer to Commercializing ViraxImmuneTM as a Full In-Vitro-Diagnostic Product'
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes
Thursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching 'ImmuneSelect' within the ViraxImmune T-Cell diagnostic platform for research-use-only (RUO) at the European Society of C
Virax Biolabs Showcases Innovations at ESCMID 2024
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
12 Health Care Stocks Moving In Friday's After-Market Session
GainersInVivo Therapeutics Hldg (NASDAQ:NVIV) shares moved upwards by 30.1% to $0.41 during Friday's after-market session. The market value of their outstanding shares is at $1.2 million. Scinai Immun
CRBP, PXLW and VVOS Among Mid-day Movers
ONMD, ATGE and BORR Among Pre-market Losers
ZIM, ACET and LUNR Are Among Pre Market Gainers
Athira Pharma, Sera Prognostics Among Healthcare Movers
SXTC, CGA and JFBR Among Pre-market Losers
Losers: Corcept Therapeutics (CORT) -33% in patent battle with Teva.
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersCyclo Therapeutics (NASDAQ:CYTH) stock rose 34.1% to $2.2 during Wednesday's after-market session. The market value of their outstanding shares is at $50.0 million. Cingulate (NASDAQ:CING) shar
Hoth Therapeutics, SCWorx Among Healthcare Movers
Virax Biolabs Forges Strategic Research Collaboration With University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
Virax Biolabs To Carry Out 1-for-10 Reverse Stock Split On December 18th, 2023
December 15th - $Virax Biolabs(VRAX.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from December 18th, 2023.$Virax Biolabs
Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation
LONDON, Dec. 14, 2023 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative diagnostics company focused on the detection of immune responses and diagnos
Top Premarket Gainers
C4 Therapeutics (CCCC) surged 59% premarket on Tuesday, following a license and research collaboration agreement with Merck (MRK) to develop degrader-antibody conjugates. Icosavax (ICVX) shares soared
Virax Biolabs Files for up to $30M Mixed Securities Shelf
Virax Biolabs Group Files For Mixed Shelf Offering Of Up To $30M
Virax Biolabs Group Files For Mixed Shelf Offering Of Up To $30M
No Data